LONDON, April 24, 2014 /PRNewswire/ --
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Cerner Corp. (NASDAQ: CERN), Ventas Inc. (NYSE: VTR), NTT DOCOMO Inc. (NYSE: DCM) and ImmunoGen Inc. (NASDAQ: IMGN). Full earnings notes on CERN, VTR, DCM and IMGN can be downloaded upon signing up at:
Cerner Corp. is scheduled to release its first-quarter FY 2014 results on Thursday, April 24, 2014, after the close of trading. The company had announced net income of $0.39 per share in the last quarter, which was in-line with the market consensus forecast. Analysts have predicted net earnings for the company at $0.37 a share, above $0.31 a share reported in the year-ago quarter. As of Wednesday, April 23, 2014, Cerner Corp.'s shares were trading at a P/E ratio of 41.98. Sign up today to read free research on CERN at:
On Friday, April 25, 2014, Ventas Inc. will be releasing its Q1 FY 2014 earnings report before the opening bell. The company reported earnings of $0.41 a share in the year-ago same quarter and analysts at Wall Street expect the company to report the same EPS for the reporting quarter as well. In the previous quarter, the company recorded earnings of $0.39 a share, below the market expectation of $0.43 a share. During the last one year, Ventas Inc.'s EPS has grown 59.05% and as of Wednesday, April 23, 2014, the company's P/E ratio was at 36.85. Sign up today to read free research on VTR at:
NTT DOCOMO Inc. will announce its fourth-quarter and financial year 2014 earnings on Friday, April 25, 2014, at 2:00 am (EST). In the last one year, the company's earnings per share has grown 6.84%. NTT DOCOMO, Inc. is a provider of various types of telecommunication services including cellular phones, satellite mobile communication, and wireless LAN Network. The company also sells cellular phones, and other equipment. Sign up today to read free research on DCM at:
Before the opening bell on Friday, April 25, 2014, ImmunoGen Inc. will report its third-quarter FY 2014 earnings. The company is expected to post net loss of $0.26 a share in the reporting quarter. In comparison, it reported net loss of $0.02 a share in the year-ago same quarter. In the last quarter, ImmunoGen Inc. posted earnings of $0.04 a share, against the analysts' net loss projection of $0.16 a share. The company's EPS has risen by 8.42% in the last one year. Sign up today to read free research on IMGN at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.earningssource.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.earningssource.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.earningssource.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Source. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Earnings Source in this article or report according to the procedures outlined by Earnings Source. Earnings Source is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Earnings Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Earnings Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Source does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Earnings Source